Rpn10 的上调通过激活 NF-κB 通路促进肾透明细胞癌的肿瘤进展。
Upregulation of Rpn10 promotes tumor progression via activation of the NF-κB pathway in clear cell renal cell carcinoma.
机构信息
State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200032, China.
出版信息
Acta Biochim Biophys Sin (Shanghai). 2021 Jul 28;53(8):988-996. doi: 10.1093/abbs/gmab078.
The ubiquitin-proteasome system (UPS) plays a central role in regulating protein homeostasis in tumor progression. The proteasome subunit Rpn10 is associated with the progression of several tumor types. However, little is known regarding the role of Rpn10 in clear cell renal cell carcinoma (ccRCC). In this study, we found that overexpression of Rpn10 increased ccRCC cell proliferation, migration, and invasion. Silencing Rpn10 expression resulted in decreased cell proli-feration, migration, and invasion in ccRCC cells. Knockdown of Rpn10 inhibits tumor growth and cell proliferation in vivo. Furthermore, we demonstrated that Rpn10 increased cell proliferation, migration, and invasion via regulation of the nuclear factor kappa B (NF-κB) pathway. Rpn10 directly promoted inhibitor of nuclear factor-kappa B alpha (IκBα) degradation through the UPS. Moreover, we observed that upregulation of Rpn10 or downregulation of IκBα in ccRCC was associated with poor prognosis. We found that the combination of these two parameters was a more powerful predictor of poor prognosis than either parameter alone. Collectively, these findings provide evidence that Rpn10 promotes the progression of ccRCC by regulation of the NF-κB pathways and is a prognostic indicator for patients with ccRCC.
泛素-蛋白酶体系统 (UPS) 在肿瘤进展过程中调节蛋白质动态平衡中发挥核心作用。蛋白酶体亚基 Rpn10 与几种肿瘤类型的进展有关。然而,关于 Rpn10 在透明细胞肾细胞癌 (ccRCC) 中的作用知之甚少。在这项研究中,我们发现 Rpn10 的过表达增加了 ccRCC 细胞的增殖、迁移和侵袭。沉默 Rpn10 表达导致 ccRCC 细胞的增殖、迁移和侵袭减少。Rpn10 的敲低抑制体内肿瘤生长和细胞增殖。此外,我们证明 Rpn10 通过调节核因子 kappa B (NF-κB) 通路增加细胞增殖、迁移和侵袭。Rpn10 通过 UPS 直接促进核因子-kappa B 抑制物 alpha (IκBα) 的降解。此外,我们观察到 ccRCC 中 Rpn10 的上调或 IκBα 的下调与预后不良有关。我们发现这两个参数的组合比任何一个参数单独预测预后不良的能力更强。总之,这些发现提供了证据表明 Rpn10 通过调节 NF-κB 通路促进 ccRCC 的进展,并且是 ccRCC 患者的预后指标。